Technologie medyczne
Firmy Pakistanu działające w jednym sektorze: technologie medyczne
These Firmy Pakistanu operate in the same sector, technologie medyczne. Each includes key stats like stock price, daily change, and trading volume to help you make more informed trading decisions. Whether you're tracking industry giants such as GLAXOSMITHKLINE PAKISTAN LIMITED or looking at high-volume movers like CITI PHARMA LIMITED, this list offers valuable insights for any trading strategy. Filter and compare companies and stay on top of market trends easily.
Symbol | Kapitalizacja rynkowa | Cena | Zmiana % | Wolumen | Realny Wolumen | Cena/Zysk | Zysk na akcję rzeczywisty TTM | Wzrost rzeczywistego zysku na akcję Ostatnie 12 miesięcy r/r | Rentowność dywidend % TTM | Ocena Analityków |
---|---|---|---|---|---|---|---|---|---|---|
125,08 B PKR | 385,00 PKR | −1,97% | 112,83 K | 0,24 | 15,14 | 25,43 PKR | +1 110,93% | 2,50% | Silne kup | |
97,62 B PKR | 974,90 PKR | −2,23% | 8,79 K | 0,76 | 17,96 | 54,29 PKR | +165,75% | 1,00% | Silne kup | |
87,76 B PKR | 730,00 PKR | −2,64% | 53,77 K | 0,75 | 16,19 | 45,08 PKR | +293,27% | 2,67% | Silne kup | |
53,7 B PKR | 187,00 PKR | −2,50% | 95,4 K | 0,21 | 16,78 | 11,14 PKR | +93,88% | 2,03% | Silne kup | |
51,22 B PKR | 942,00 PKR | −2,55% | 32,27 K | 1,09 | 14,03 | 67,16 PKR | +34,63% | 4,29% | — | |
47,51 B PKR | 90,29 PKR | −2,80% | 2,27 M | 0,34 | 36,70 | 2,46 PKR | — | 0,00% | Silne kup | |
33,08 B PKR | 3 480,00 PKR | +1,47% | 869 | 4,26 | 16,18 | 215,10 PKR | +96,87% | 4,08% | — | |
20,67 B PKR | 85,58 PKR | −2,94% | 2,62 M | 0,70 | 23,53 | 3,64 PKR | +3,09% | 3,59% | — | |
18,11 B PKR | 386,00 PKR | −2,34% | 2,32 K | 0,13 | 28,93 | 13,34 PKR | +74,29% | 0,70% | — | |
17,09 B PKR | 381,89 PKR | −2,87% | 109,53 K | 0,27 | 22,03 | 17,34 PKR | +52,60% | 0,75% | — | |
4,82 B PKR | 375,00 PKR | −5,91% | 73,1 K | 0,21 | 145,12 | 2,58 PKR | −62,93% | 0,00% | — | |
— | 56,80 PKR | −3,43% | 254,85 K | 0,69 | — | — | — | — | — | |
— | 176,00 PKR | −3,03% | 486,84 K | 0,34 | — | — | — | — | — |